Charles Schwab’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.7M | Buy |
3,583,382
+269,489
| +8% | +$2.61M | 0.01% | 1332 |
|
|
2025
Q1 | $49.3M | Sell |
3,313,893
-19,810
| -0.6% | -$295K | 0.01% | 1080 |
|
|
2024
Q4 | $49.7M | Buy |
3,333,703
+10,652
| +0.3% | +$159K | 0.01% | 1129 |
|
|
2024
Q3 | $63.6M | Buy |
3,323,051
+875,128
| +36% | +$16.7M | 0.01% | 933 |
|
|
2024
Q2 | $50.7M | Buy |
2,447,923
+124
| +0% | +$2.57K | 0.01% | 1067 |
|
|
2024
Q1 | $46M | Buy |
2,447,799
+164,900
| +7% | +$3.1M | 0.01% | 1104 |
|
|
2023
Q4 | $32.9M | Sell |
2,282,899
-102,278
| -4% | -$1.47M | 0.01% | 1279 |
|
|
2023
Q3 | $41.4M | Buy |
2,385,177
+173,977
| +8% | +$3.02M | 0.01% | 1010 |
|
|
2023
Q2 | $46M | Buy |
2,211,200
+53,876
| +2% | +$1.12M | 0.01% | 898 |
|
|
2023
Q1 | $50.7M | Buy |
2,157,324
+266,215
| +14% | +$6.26M | 0.02% | 818 |
|
|
2022
Q4 | $52.8M | Buy |
1,891,109
+61,937
| +3% | +$1.73M | 0.02% | 772 |
|
|
2022
Q3 | $42.8M | Buy |
1,829,172
+47,689
| +3% | +$1.12M | 0.02% | 858 |
|
|
2022
Q2 | $60.1M | Buy |
1,781,483
+21,963
| +1% | +$741K | 0.02% | 658 |
|
|
2022
Q1 | $61.5M | Sell |
1,759,520
-2,665,985
| -60% | -$93.1M | 0.02% | 745 |
|
|
2021
Q4 | $135M | Buy |
4,425,505
+177,376
| +4% | +$5.4M | 0.04% | 409 |
|
|
2021
Q3 | $139M | Buy |
4,248,129
+317,585
| +8% | +$10.4M | 0.05% | 371 |
|
|
2021
Q2 | $119M | Buy |
+3,930,544
| New | +$119M | 0.04% | 425 |
|